These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10022441)

  • 1. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies.
    Chazenbalk GD; Wang Y; Guo J; Hutchison JS; Segal D; Jaume JC; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 1999 Feb; 84(2):702-10. PubMed ID: 10022441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
    Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
    Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
    Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
    Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera.
    Chazenbalk GD; Jaume JC; McLachlan SM; Rapoport B
    J Biol Chem; 1997 Jul; 272(30):18959-65. PubMed ID: 9228077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
    Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
    J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate.
    Rapoport B; McLachlan SM; Kakinuma A; Chazenbalk GD
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2525-33. PubMed ID: 8675572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting linear and conformational epitopes on the native thyrotropin receptor.
    Ando T; Latif R; Daniel S; Eguchi K; Davies TF
    Endocrinology; 2004 Nov; 145(11):5185-93. PubMed ID: 15297445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors.
    Schwarz-Lauer L; Pichurin PN; Chen CR; Nagayama Y; Paras C; Morris JC; Rapoport B; McLachlan SM
    Endocrinology; 2003 May; 144(5):1718-25. PubMed ID: 12697676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
    Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies interacting with purified native thyrotropin receptor.
    Atger M; Misrahi M; Young J; Jolivet A; Orgiazzi J; Schaison G; Milgrom E
    Eur J Biochem; 1999 Nov; 265(3):1022-31. PubMed ID: 10518798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
    Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor.
    Schwarz-Lauer L; Chazenbalk GD; Mclachlan SM; Ochi Y; Nagayama Y; Rapoport B
    Thyroid; 2002 Feb; 12(2):115-20. PubMed ID: 11916280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
    Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.